Abstract
Research data from the past decade indicate that noble gases like xenon and helium exert profound cardioprotection when applied before, during or afte r organ ischemia. Of all noble gases, especially helium, has gained interest in the past years because it does not have an anesthetic “side effect” like xenon, allowing application of this specific gas in numerous clinical ischemia/reperfusion situations. Because helium has several unique characteristics and no hemodynamic side effects, helium could be administered in severely ill patients. Investigations in animals as well as in humans have proven that this noble gas is not completely inert and can induce several biological effects. Though the underlying molecular mechanisms of helium-induced cardiac protection are still not yet fully understood, recently different signaling pathways have been elucidated.
Keywords: Cardioprotection, conditioning, helium, mechanism, noble gases.
Current Drug Targets
Title:Targets Involved in Cardioprotection by the Non-Anesthetic Noble Gas Helium
Volume: 16 Issue: 8
Author(s): Nina C. Weber, Kirsten F. Smit, Markus W. Hollmann and Benedikt Preckel
Affiliation:
Keywords: Cardioprotection, conditioning, helium, mechanism, noble gases.
Abstract: Research data from the past decade indicate that noble gases like xenon and helium exert profound cardioprotection when applied before, during or afte r organ ischemia. Of all noble gases, especially helium, has gained interest in the past years because it does not have an anesthetic “side effect” like xenon, allowing application of this specific gas in numerous clinical ischemia/reperfusion situations. Because helium has several unique characteristics and no hemodynamic side effects, helium could be administered in severely ill patients. Investigations in animals as well as in humans have proven that this noble gas is not completely inert and can induce several biological effects. Though the underlying molecular mechanisms of helium-induced cardiac protection are still not yet fully understood, recently different signaling pathways have been elucidated.
Export Options
About this article
Cite this article as:
Weber C. Nina, Smit F. Kirsten, Hollmann W. Markus and Preckel Benedikt, Targets Involved in Cardioprotection by the Non-Anesthetic Noble Gas Helium, Current Drug Targets 2015; 16 (8) . https://dx.doi.org/10.2174/1389450116666150120104459
DOI https://dx.doi.org/10.2174/1389450116666150120104459 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nitric Oxide: News from Stem Cells to Platelets
Current Medicinal Chemistry Endocannabinoid Regulation of Matrix Metalloproteinases: Implications in Ischemic Stroke
Cardiovascular & Hematological Agents in Medicinal Chemistry Prevention of Sudden Cardiac Death in Hemodialysis Patients
Cardiovascular & Hematological Disorders-Drug Targets Atheroma Burden and Morphology in Women
Current Pharmaceutical Design Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
Current Drug Targets - Cardiovascular & Hematological Disorders Modulation of PMN-Endothelial Cells Interactions by Cyclic Nucleotides
Current Pharmaceutical Design Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Current Neuropharmacology Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A<sub>2</sub> (Lp-PLA<sub>2</sub>) Bound to LDL and HDL
Current Pharmaceutical Design Ex Vivo Gene Transfer for Improvement of Transplanted Pancreatic Islet Viability and Function
Current Pharmaceutical Design Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Cardiovascular Effects of Omega-3 Free Fatty Acids.
Current Vascular Pharmacology Sex-Genetic Interaction in the Risk for Cerebrovascular Disease
Current Medicinal Chemistry Possible Links of Age Related Hypertension and Evolution Imposed Features of Heart and Aorta
Current Aging Science Targeting the Toll-System in Cardiovascular Sciences
Recent Patents on Inflammation & Allergy Drug Discovery Clinical Management of the Cardiovascular Failure in Sepsis
Current Vascular Pharmacology Molecular Targets of Diabetic Cardiovascular Complications
Current Drug Targets Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia
Current Pharmaceutical Biotechnology B-Type Natriuretic Peptide for Diagnosis and Therapy
Recent Patents on Cardiovascular Drug Discovery Melatonin in Bacterial and Viral Infections with Focus on Sepsis: A Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)